To test if carbachol (CCh)-evoked Ca 2+ oscillations in freshly isolated murine detrusor myocytes are affected by b3-adrenoceptor (b-AR) modulators.
Introduction b3-adrenoceptor (b3-AR) agonists, such as mirabegron, represent a novel class of drugs to treat overactive bladder (OAB) syndrome [1, 2] ; however, there is little agreement on either the site of or mechanism of action for these drugs. Indeed, a recent editorial by Okeke et al. [3] described how various investigators, even within the same institute, using similar approaches and antibodies have obtained conflicting results, with no obvious explanation for the divergent findings. These authors concluded that additional studies are required to determine the functional responses of cells involved in detrusor tone to application of b3-AR agonists.
The b3-AR agonists inhibit detrusor contractions induced by cholinergic stimulation [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , and much of the current debate is centred around whether these effects are brought about by a direct effect on the detrusor [4, 14, 15] , inhibition of acetylcholine (ACh) release from cholinergic nerves [12] , or a combination of both [11] . A recent study by Silva et al. [16] , however, appeared to reconcile these disparate views by demonstrating that b3-AR agonists bound to post-junctional b3-ARs on detrusor myocytes, causing release of adenosine which reduced ACh output from cholinergic nerves. b3-AR agonists, therefore, appear to target post-junctional b3-ARs on detrusor myocytes, but little is known about the cellular mechanisms that are affected by their stimulation.
Muscarinic receptor-induced contractions of the detrusor are associated with a rise in intracellular Ca 2+ and the development of Ca 2+ waves in detrusor myocytes [17, 18] . It is currently unknown if these events are affected by b3-AR activation; however, the selective b3-AR agonist BRL37344 inhibited Ca 2+ transients in guinea-pig heart preparations [19] ; therefore, it is possible that stimulation of b3-ARs in detrusor myocytes could also affect Ca 2+ signalling. The aim of the present study was to test if carbachol (CCh)-evoked Ca 2+ oscillations in freshly isolated murine detrusor myocytes were affected by the b3-AR agonists BRL37344 and CL316,243.
Materials and Methods

Ethics Approval
All procedures were carried out in accordance with EU Directive 2010/63/EU and with approval from Dundalk Institute of Technology Animal Care and Use Committee.
Tissue Preparation and Cell Isolation
Six-week-old male and female C57BL/6 mice (Envigo, Huntingdon, UK) were killed by cervical dislocation. Bladders were removed, opened longitudinally and pinned to a Sylgard Petri dish, with the luminal side facing upwards. The mucosa was removed by sharp dissection, exposing the detrusor. Two strips of detrusor from each bladder were used for tension recording, cell dispersal or molecular biology. Strips of detrusor were cut into pieces (~1 mm 
Tension Recordings
Detrusor strips (~8 mm in length) were mounted in waterjacketed organ baths, maintained at 37°C and bathed with Krebs' solution bubbled with 95% O 2 -5% CO 2 . Strips were adjusted to a tension of 2-4 mN and allowed to equilibrate for 50 min. Contractions were recorded using the multichannel Myobath system and data acquired using DATATRAX2 software (WPI, Hertfordshire, UK). These data were analysed using DATATRAX2 software, and normalized to the amplitude of the sustained tension response after 15 min.
Ca
2+ Imaging
Isolated detrusor myocytes were loaded with 0.4 lM fluo-4/ AM and imaged using an iXon887 EMCCD camera (Andor Technology, Belfast, UK), coupled to a Nipkow spinning disk confocal head (CSU22, Yokogawa, Japan) as described previously [20] . A krypton-argon laser (Melles Griot, Cambridge, UK) at 488 nm was used to excite the fluo-4, and the emitted light was detected at wavelengths >510 nm. Experiments were performed using a 960 objective (Olympus, Cardiff, UK), resulting in images of pixel size 0.266 9 0.266 lm. Images were acquired at 15 frames per second. Background fluorescence from the camera, obtained using a null frame, was subtracted from each frame to obtain 'F'. Plots of the fluorescence were normalized by dividing by F 0 , or the 'basal Ca 2+ ', defined as the minimum fluorescence measured on the cell between oscillations in the control period. The 'amplitude' of the Ca 2+ events was taken as the change in F/F 0 units, DF/F 0 averaged over the whole cell. For display purposes two-dimensional images of the recordings were created by drawing a line down the long axis of the cell and invoking the 'reslice' command in IMAGEJ. This command displays the pixel intensity along a series of lines, each of which corresponds to a single frame of the movie stack. These are aligned vertically, left to right, to obtain a pseudolinescan, so that the vertical direction (y) corresponds to distance along the cell, the horizontal direction corresponds to time (t), and the intensity (brightness) corresponds to the Ca 2+ level. The intensity was pseudo-coloured so that 'hotter' colours corresponded to increased Ca 2+ levels.
Electrophysiology L-type Ca 2+ currents were recorded using the perforated patch configuration of the whole cell patch clamp technique using amphotericin B (60 lg/mL), as described previously [21] .
Molecular Biology
Total RNA from tissue strips was prepared using the Trizol method (Invitrogen, Carlsbad, CA, USA). RNA samples were DNase (DNase 1; Invitrogen) treated to remove any contaminating genomic DNA. First-strand cDNA was prepared from tissue RNA preparations using SuperscriptII Reverse Transcriptase (Invitrogen). 200 lg/lL random hexamers were used to reverse transcribe RNA.
Real-time quantitative PCR (qPCR) was performed on a QUANTICA real-time PCR system (TECHNE) using the SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The cycling conditions were as follows: an initial 5-min denaturation at 95°C was followed by 40 cycles of: denaturation at 95°C for 30 s, annealing at 56°C for 1 min, extension at 72°C for 45 s. Tissue samples were analysed in triplicate with cDNA obtained from three different mice. In addition, non-template controls were included for all primer sets. After real-time qPCR acquisition, a dissociation curve (70°C-90°C) was obtained. Subsequent analysis of the individual melting curves allowed us to verify the specificity of primer sets. b-actin was used as a reference gene for quantification of b1-, b2-and b3-ARs in murine detrusor. Standard curves were generated, for the reference 
Immunofluorescence
Cells were fixed in 2% paraformaldehyde (Sigma) in PBS solution (Gibco, Carlsbad, CA, USA), for 30 min at 4°C and washed with PBS (3 9 5 min). This was followed by permeabilization using Triton X-100 (0.3%; Sigma) and blocking using 3% normal donkey serum (in PBS, 10 min). Cells were incubated in anti-b3-AR primary antibody (SC-1473, Santa Cruz Biotechnology, Dallas, TX, USA) overnight at 4°C. The primary antibody was removed by a 3 9 5-min PBS washing step. Cells were incubated in secondary antibody (Alexa Fluor 488; Invitrogen), 1:1 000 dilution for 1 h at 4°C. The secondary antibody was removed by a 5 9 5-min PBS washing step. Secondary antibody control dishes were prepared in a similar manner by omitting the primary antibody incubation step. Control dishes were imaged using the same parameters for each experiment. No positive immunoreactivity occurred.
Immunofluorescence of isolated detrusor SMCs was imaged using an Axioskop 2 LSM 510 Meta confocal microscope (Zeiss, Oberkochen, Germany). A water-dipping 920 objective lens was lowered into the dish and cells were focused in transmitted light. Using a laser, excitation wavelengths of 488 nm were used to visualize immunoreactivity in the cells. The emission filter used was 505-530 nm (green). Confocal micrographs were composited of z-series scans of~8-12 optical sections, taken at 0.5-lm depth intervals. Final images were constructed using the zstack function within IMAGE J software.
Solutions
Solutions were of the following composition (mM): Krebs' solution: NaCl (120), KCl (5.9), NaHCO 3 (25) 
Drugs
The drugs used were as follows: 
Statistics
In each data set 'n' reflects the number of cells or tissue strips and 'N' refers to the number of animals from which these were obtained. A maximum of two detrusor strips were obtained from each animal. Statistical analysis was performed using one-way ANOVA (with a Bonferoni post hoc test) or a Student's paired t-test, where appropriate. P values <0.05 were taken to indicate statistical significance.
Results
b3-ARs represent 97% of all b-ARs expressed in human detrusor [22] ; however, in murine detrusor Wuest et al. [15] reported that b3-AR expression was approximately three times lower than that of b2-AR and~12 times lower than that of b1-AR [15] . We re-examined the expression of b-AR transcripts in murine detrusor, with the mucosa removed, using a combination of qualitative and quantitative PCR. Figure 1A shows that transcripts for b1-, b2-and b3-AR were all detected, but real-time qPCR analysis (Fig. 1B) showed that b3-ARs were the most abundant sub-type, accounting for~71% of b-AR transcripts in the murine detrusor, followed by b2-AR (~27%) and b1-AR (~2%). The representative confocal photomicrographs in Fig. 1C ,D confirms that SMCs isolated from the murine detrusor were immunoreactive for b3-ARs, demonstrable by the strong inmmunofluorescence at the cell membrane. Figure 1E ,F are secondary antibody-only controls, demonstrating that no immunofluorescence was observed when the primary antibody was omitted.
Experiments were next performed to test if CCh-evoked contractions of murine detrusor strips were reduced by the selective b3-AR agonist, BRL37344 and, if so, whether this effect was mediated by activation of BK channels. Application of CCh (300 nM) evoked contractions consisting of an initial transient contraction, followed by a sustained response ( Fig. 2A) . Cumulative application of BRL37344 (1, 10 and 30 lM), applied during the sustained phase of the CCh contraction, relaxed the detrusor in a concentrationdependent fashion (Fig. 2B ). Similar effects were observed when BRL37344 was applied to the same muscle strip in the presence of the BK channel blocker, IbTX (100 nM; Fig. 2C ). Figure 2D is a summary plot of the mean amplitude of CCh responses in the presence of increasing concentrations of BRL37344 (0.03-30 lM) before (n = 6) and during the presence of IbTX (n = 6), respectively. A plot of the CCh responses in the absence of BRL37344 (time controls) is also shown (n = 6). These concentration-effect curves were obtained from preparations when the BRL37344 was added after a CCh incubation period of 45 min when the tissues had reached a steady-state level of contraction (Fig. S1 ). The half maximum inhibitory concentration (IC 50 ) value for BRL37344 on CCh responses was 2.4 lM (95% CI 1.3-4.4 lM) in the absence of IbTX and 2.1 lM (95% CI 1.0-4.1 lM) in its presence.
Detrusor contractions evoked by CCh are associated with a rise in intracellular Ca 2+ concentration, therefore, we next examined if CCh-evoked Ca 2+ transients in freshly isolated murine detrusor myocytes were affected by BRL37344. The representative pseudo-linescan image and corresponding intensity profile plot in Fig. 3A ,B show that application of BRL37344 (10 lM) reversibly reduced the amplitude and frequency of CCh-induced Ca 2+ oscillations. Figure 3C is a summary bar chart which shows that the inhibitory effects of BRL37344 on CCh-induced Ca 2+ oscillations were concentration-dependent. For example, the mean amplitude of the initial CCh transient was reduced from 4.2 AE 0.3 ΔF/ F 0 (n = 21) to 1.4 AE 0.25 and 0.4 AE 0.1 ΔF/F 0 in the presence of 10 and 30 lM BRL37344, respectively (P < 0.001, n = 9 and n = 6, respectively, one-way ANOVA, unpaired). The representative traces in Fig. 4A ,B indicate that CL316,243, a different b3-AR agonist, also reduced the amplitude of CChinduced Ca 2+ oscillations in mouse detrusor myocytes. The summary plot in Fig. 4C shows that 10 lM CL316,243 reduced the mean amplitude of CCh oscillations from 3.9 AE To confirm that the inhibitory effects of BRL37344 were mediated by b3-ARs, and not b1-or b2-ARs, the effect of BRL37344 was compared in the presence of a selective b3-AR antagonist, L-748,337 or propranolol, which inhibits b1-and b2-ARs. Figure 5A -C indicate that the inhibitory effects of BRL37344 (10 lM) on CCh-induced Ca 2+ oscillations were reduced by the b3-AR antagonist, L-748,337 (1 lM). The mean amplitude of the CCh response under control conditions was 3.4 AE 0.6 ΔF/F 0 compared with 3.5 AE 0.6 ΔF/ F 0 in the presence of L-748,337 and 3.0 AE 0.5 ΔF/F 0 in L-748,337 plus BRL37344 (P > 0.05, one-way ANOVA, n = 6, N = 4). When L-748,337 was washed out, BRL37344 significantly reduced the CCh response to 2.15 AE 0.5 ΔF/F 0 (P < 0.001). In contrast, BRL37344 (10 lM) significantly reduced CCh responses in the presence of propranolol (1 lM), from 4.96 AE 0.6 ΔF/F 0 to 2.6 AE 0.7 ΔF/F 0 (Fig. 6A-C , P < 0.001, one-way ANOVA, n = 6, N = 4).
To test if the effects of BRL37344 were brought about by depletion of intracellular Ca 2+ stores, we examined its effects on caffeine-induced Ca 2+ transients, which causes release of Ca 2+ from the sarcoplasmic reticulum by sensitizing ryanodine receptors to Ca 2+ [23] . Application of caffeine (10 mM) induced reproducible Ca 2+ transients, but they were not affected by BRL37344 (30 lM, Fig. 7A,B) . The summary plot in Fig. 7D indicates that the mean amplitude of the caffeine response under control conditions was 4.1 AE 0.9 ΔF/ F 0 vs 3.8 AE 0.9 ΔF/F 0 in 30 lM BRL37344 (P > 0.05, paired t-test, n = 6, N = 3).
Finally, as CCh responses in the detrusor rely on Ca 2+ influx via L-type Ca 2+ channels, experiments were performed to examine if L-type Ca 2+ currents in isolated detrusor myocytes were affected by BRL37344. Figure 7C is representative trace showing L-type Ca 2+ currents, evoked by step depolarization to 0 mV from a holding potential of À60 mV, before and in the presence of BRL37344 (10 lM). The mean peak amplitude of L-type Ca 2+ current was not significantly affected by BRL37344 (À229 AE 96 pA before vs À228 AE 99 pA in BRL37344 (P > 0.05, n = 5, N = 2; Fig. 7E ).
Discussion
Determination of the site and mechanism of action of b3-AR agonists, such as mirabegron, for treatment of OAB is currently the subject of intense debate within the field [1] [2] [3] . Several cell types within the bladder have been reported either to express b3-ARs or be responsive to b3-AR agonists, including detrusor smooth muscle, urothelium, afferent nerves, interstitial cells, blood vessels and the major pelvic ganglion [2] . A recent study by Coelho et al. [24] found that b3-ARs were primarily expressed in nerve fibres in the mucosa and muscle layers of the bladder but not in urothelium or smooth muscle; however, Silva et al. [16] showed that b3-AR immunofluorescence was higher in the smooth muscle layer, compared with the urothelium and suburothelium. In the present study we found that b3-AR transcripts were the most abundant b-AR sub-type in the mouse detrusor and that robust b3-AR immunoreactivity was present in isolated detrusor myocytes, providing strong evidence that b3-ARs are present in bladder smooth muscle.
Mirabegron, BRL37344 and CL316,243 are all regarded as selective b3-AR agonists; however, while mirabegron, is used in clinical practice to treat OAB, its potency is eightfold lower for rodent bladder compared with human [25] . Conversely, BRL37344 and CL316,243 are more potent and efficacious in stimulating rodent b3-ARs, compared with human [26, 27] . In the present study, therefore, we used BRL37344 and CL316,243 to examine the effects of b3-AR activation on cholinergic responses in the murine detrusor. BRL37344 relaxed strips of detrusor that were pre-contracted with CCh and reduced the amplitude of CCh-induced Ca 2+ oscillations and 30 lM BRL37344. ***P < 0.001.
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© 2017 The Authors BJU International © 2017 BJU International in freshly isolated murine detrusor myocytes. The latter effect was mimicked by CL316,243, another b3-AR agonist and inhibited by L-748,337, a b3-AR antagonist. In contrast, propranolol, an antagonist of b1-and b2-ARs, failed to inhibit the effects of BRL37344. Inhibition of CCh-induced contractions by BRL37344 was not prevented by the BK channel blocker IbTX and BRL37344 did not reduce the amplitude of L-type Ca 2+ current or caffeine-evoked Ca 2+ transients in isolated detrusor myocytes; therefore, b3-ARmediated inhibition of cholinergic responses in the murine detrusor does not involve activation of BK channels, inhibition of Ca 2+ influx via L-type Ca 2+ channels or impaired Ca 2+ release from, or refilling of, caffeine-sensitive intracellular Ca 2+ stores. These findings appear to contrast with others that support a role for Ca 2+ -activated K + (BK) channel activation in the inhibitory effects of b-AR agonists in the detrusor. For example, Hristov et al. [28] indicated that stimulation of b3-ARs relaxes rat detrusor by activating BK channels, resulting in membrane hyperpolarization and thus relaxation. The data in the present study suggest that inhibitory effects of b3-AR agonists on CCh-evoked contractions of the detrusor are associated with inhibition of the Ca 2+ oscillations that underlie these responses. The mechanisms that underlie cholinergic-induced Ca 2+ oscillations, however, are still unclear.
Cholinergic responses in the detrusor are mediated by activation of M3 muscarinic receptors (M3Rs) that are functionally coupled to G q/11 proteins which activate the PLC/IP 3 pathway. Despite this, M3R-mediated responses in the detrusor do not appear to involve release of Ca 2+ from IP 3 Rs. For example, Schneider et al. [29] showed that while the PLC inhibitor U73122 completely blocked CCh-induced accumulation of inositol phosphates, it did not inhibit CChinduced contractions. Similarly, Nausch et al. [30] found that inhibition of PLC with U73122 had little effect on nerveevoked contractions. Griffin et al. [31] reported that the IP 3 R inhibitor 2-APB did not affect murine detrusor contractions evoked by low frequency (2Hz) EFS, but reduced those evoked at 8Hz by~25% [31] . Taken together, these findings indicate that inhibition of IP 3 -mediated Ca 2+ release is unlikely to account for the effects of BRL37344 on cholinergic responses in the present study.
In contrast to the effect of IP 3 R and PLC blockers, several studies have confirmed that cholinergic contractions of the detrusor are inhibited by blockers of voltage-gated Ca 2+ channels (VGCCs) [29, 30] ; however, the mechanisms linking stimulation of M3Rs to activation of VGCCs have not been clarified. Griffin et al. [31] showed that 2-APB-resistant contractions of murine detrusor were almost completely abolished by the TRPC4/5 channel blocker ML204, suggesting that TRPC4/5 channels could be involved in M3R-mediated contractions of the detrusor, possibly by providing the depolarizing current required to activate VGCCs. The findings of the present study show that BRL37344 does not directly affect L-type Ca 2+ currents in murine detrusor myocytes, but it is possible that it could reduce CCh responses by inhibiting TRPC4/5 channels. Consistent with this idea are findings from Sung et al. [32] , which showed that muscarinic receptor-mediated TRPC4 currents in HEK The maximum plasma levels achieved by therapeutic dosing (50 mg daily) of mirabegron are in the range 83-167 nM, which is notably lower than the IC 50 value for inhibition of CCh-induced contractions by BRL37344 in the present study (2.4 lM) [33] . Differences in species and b 3 -AR agonists, however, as noted above, make extrapolation of findings between rodent and human models notoriously difficult to reconcile [16] . Furthermore, pharmacological investigations on freshly isolated single cells often employ higher concentrations of drugs, both to exaggerate effects that are observed and also to compensate for degradation of cell surface proteins that occurs during the enzymatic cell dispersal process; therefore, it is difficult to accurately determine the contribution of the effects observed in the present study to the therapeutic properties of mirabegron for treatment of OAB. Future studies should examine if mirabegron affects cholinergic-mediated Ca 2+ oscillations in isolated human detrusor myocytes.
The results of the present study are in agreement with others which have shown that b3-AR agonists inhibit cholinergicmediated contractions of the detrusor induced by electric field stimulation or application of cholinergic agonists [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Despite this, b3-AR agonists have little, or no, effect on voiding contractions in humans, that are mediated by neuronal release of ACh [1] ; therefore, at first glance it appears that the therapeutic effects of these drugs are not related to inhibition of cholinergic responses, such as those observed in the present study. It is now recognized, however, that the therapeutic effect of anti-cholinergic drugs are not related to inhibition of voiding contractions but rather to an action during the storage phase that increases bladder capacity and thus decreases urgency [34] . During the filling phase the detrusor displays spontaneous, non-voiding, contractions that are insensitive to tetrodotoxin and atropine but can be augmented by ACh [35, 36] . Drake et al. [37] showed that this activity was increased in patients with detrusor overactivity and Biers et al. [6] and Gillespie et al. [38] showed that spontaneous contractions of human detrusor were inhibited by b3-AR agonists. Potential reasons as to why b3-AR agonists may affect ACh responses during 
968
© 2017 The Authors BJU International © 2017 BJU International the storage, but not the voiding phase are unclear, but may be related to the lower ACh levels that are present during the storage phase. For example, Takasu et al. [25] showed that the IC 50 value of mirabegron required to relax rat bladder strips, contracted with 10 À6 CCh was 5.1 lM compared with 0.78 lM when 10 À7 CCh was used.
In conclusion, the present study shows that b3-AR agonists reduced the amplitude of CCh-induced Ca 2+ oscillations in isolated detrusor myocytes, offering a novel explanation for the effect of these drugs on cholinergic-mediated contractions of the detrusor. BRL37344-induced relaxations were unaffected by application of the BK channel blocker IbTX and BRL37344 did not affect L-type Ca 2+ current or caffeineevoked Ca 2+ transients in detrusor myocytes, suggesting that BRL37344 acts specifically on the intracellular pathways activated by stimulation of muscarinic receptors on detrusor myocytes.
